Other studies corroborate that laboratory parameters indicating coagulation abnormalities, such as elevated D-dimer and FDP levels, prolonged PT, and aPTT, are associated with mortality in COVID-19 patients [22,72]. The gene discussed is F2; the disease is COVID-19.